Lanean...
Impact of serogroup A meningococcal conjugate vaccine for Africa
The introduction of a serogroup A meningococcal conjugate vaccine in the African meningitis belt has been a remarkable success. Meningitis due to the serogroup A meningococcus, previously responsible for most epidemics, has fallen by 99% in vaccinated countries. Success must, however, not distract f...
Gorde:
| Argitaratua izan da: | Hum Vaccin Immunother |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989890/ https://ncbi.nlm.nih.gov/pubmed/29194010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1412022 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|